Find Vernakalant Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 748810-28-8, Vernakalant hcl, Brinavess, Kynapid, Vernakalant (hydrochloride), Rsd1235
Molecular Formula
C20H32ClNO4
Molecular Weight
385.9  g/mol
InChI Key
JMHYCBFEEFHTMK-IIUXMCBISA-N
FDA UNII
7G4J1ZD9UQ

Vernakalant Hydrochloride
1 2D Structure

Vernakalant Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol;hydrochloride
2.1.2 InChI
InChI=1S/C20H31NO4.ClH/c1-23-19-8-7-15(13-20(19)24-2)10-12-25-18-6-4-3-5-17(18)21-11-9-16(22)14-21;/h7-8,13,16-18,22H,3-6,9-12,14H2,1-2H3;1H/t16-,17-,18-;/m1./s1
2.1.3 InChI Key
JMHYCBFEEFHTMK-IIUXMCBISA-N
2.1.4 Canonical SMILES
COC1=C(C=C(C=C1)CCOC2CCCCC2N3CCC(C3)O)OC.Cl
2.1.5 Isomeric SMILES
COC1=C(C=C(C=C1)CCO[C@@H]2CCCC[C@H]2N3CC[C@H](C3)O)OC.Cl
2.2 Other Identifiers
2.2.1 UNII
7G4J1ZD9UQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Rsd 1235

2. Rsd-1235

3. Rsd1235

4. Vernakalant

2.3.2 Depositor-Supplied Synonyms

1. 748810-28-8

2. Vernakalant Hcl

3. Brinavess

4. Kynapid

5. Vernakalant (hydrochloride)

6. Rsd1235

7. Vernakalant Hydrochloride [usan]

8. Rsd-1235

9. 7g4j1zd9uq

10. (3r)-1-((1r,2r)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)pyrrolidin-3-ol Hydrochloride

11. Vernakalant Hydrochloride (usan)

12. Rsd 1235

13. Unii-7g4j1zd9uq

14. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol Hydrochloride

15. Schembl439679

16. Chembl2107383

17. Dtxsid30976007

18. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol;hydrochloride

19. Yeb81028

20. Vernakalant Hydrochloride [mi]

21. Cs-0799

22. Mk-6621

23. Vernakalant Hydrochloride [mart.]

24. As-58436

25. Hy-14183

26. Vernakalant Hydrochloride [who-dd]

27. Vernakalant Hydrochloride [ema Epar]

28. C76396

29. D06665

30. A915186

31. Q27268233

32. Rsd1235 Hydrochloride;rsd 1235 Hydrochloride;rsd-1235 Hydrochloride

33. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol Hydrochloride

34. 1-{2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}pyrrolidin-3-ol--hydrogen Chloride (1/1)

35. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol Monohydrochloride

36. 3-pyrrolidinol, 1-((1r,2r)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)-, Hydrochloride, (3r)-

37. 605683-48-5

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 385.9 g/mol
Molecular Formula C20H32ClNO4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass385.2019862 g/mol
Monoisotopic Mass385.2019862 g/mol
Topological Polar Surface Area51.2 Ų
Heavy Atom Count26
Formal Charge0
Complexity394
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults:

- for non-surgery patients: atrial fibrillation < /= 7 days duration;

- for post-cardiac surgery patients: atrial fibrillation < /= 3 days duration.


5 Pharmacology and Biochemistry
5.1 ATC Code

C01BG11


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty